» Articles » PMID: 24957775

Glycomics Approaches for the Bioassay and Structural Analysis of Heparin/heparan Sulphates

Overview
Journal Metabolites
Publisher MDPI
Date 2014 Jun 25
PMID 24957775
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The glycosaminoglycan heparan sulphate (HS) has a heterogeneous structure; evidence shows that specific structures may be responsible for specific functions in biological processes such as blood coagulation and regulation of growth factor signalling. This review summarises the different experimental tools and methods developed to provide more rapid methods for studying the structure and functions of HS. Rapid and sensitive methods for the facile purification of HS, from tissue and cell sources are reviewed. Data sets for the structural analysis are often complex and include multiple sample sets, therefore different software and tools have been developed for the analysis of different HS data sets. These can be readily applied to chromatographic data sets for the simplification of data (e.g., charge separation using strong anion exchange chromatography and from size separation using gel filtration techniques. Finally, following the sequencing of the human genome, research has rapidly advanced with the introduction of high throughput technologies to carry out simultaneous analyses of many samples. Microarrays to study macromolecular interactions (including glycan arrays) have paved the way for bioassay technologies which utilize cell arrays to study the effects of multiple macromolecules on cells. Glycan bioassay technologies are described in which immobilisation techniques for saccharides are exploited to develop a platform to probe cell responses such as signalling pathway activation. This review aims at reviewing available techniques and tools for the purification, analysis and bioassay of HS saccharides in biological systems using "glycomics" approaches.

Citing Articles

Glycosaminoglycanomics: where we are.

Ricard-Blum S, Lisacek F Glycoconj J. 2016; 34(3):339-349.

PMID: 27900575 DOI: 10.1007/s10719-016-9747-2.


RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues.

Van Gemst J, Loeven M, de Graaf M, Berden J, Rabelink T, Smit C PLoS One. 2016; 11(11):e0167336.

PMID: 27898729 PMC: 5127559. DOI: 10.1371/journal.pone.0167336.

References
1.
Winterbourne D, Mora P . Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation. J Biol Chem. 1981; 256(9):4310-20. View

2.
Thanawiroon C, Rice K, Toida T, Linhardt R . Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J Biol Chem. 2003; 279(4):2608-15. DOI: 10.1074/jbc.M304772200. View

3.
Lyon M, Gallagher J . Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver. Biochem J. 1991; 273(Pt 2):415-22. PMC: 1149861. DOI: 10.1042/bj2730415. View

4.
Turnbull J, Miller R, Ahmed Y, Puvirajesinghe T, Guimond S . Glycomics profiling of heparan sulfate structure and activity. Methods Enzymol. 2010; 480:65-85. DOI: 10.1016/S0076-6879(10)80004-7. View

5.
Hitchcock A, Yates K, Costello C, Zaia J . Comparative glycomics of connective tissue glycosaminoglycans. Proteomics. 2008; 8(7):1384-97. PMC: 2577024. DOI: 10.1002/pmic.200700787. View